FDA Approves ORZEYFUL: First Medicine to Treat the Root Cause of Narcolepsy Type 1
Twice-daily pill improves wakefulness and reduces symptoms.
Already have an account? Sign in.
Twice-daily pill improves wakefulness and reduces symptoms.
IonQ stock rose on strong results while D-Wave shares dropped after missing revenue forecasts, despite a 1,120% bookings surge in H1 2026.
Peloton reports its first-ever annual net profit but shares fall as FY2027 revenue is set to decline amid ongoing subscriber losses.
Despite beating estimates and lifting full-year outlook, Datadog shares fell sharply on soft Q3 sequential growth guidance.